Coriell Life Sciences
The business, the turning points, and the decisions behind them.
Some sections are still being researched1 / 4
Sections to complete：02
01 / WHAT IT BUILT
What the company did
Coriell Life Sciences (CLS) was a precision-medicine company spun out of the Coriell Institute for Medical Research in 2013 by CEO Scott Megill. Drawing on six decades of scientific expertise, it bridged the gap between genetic knowledge and clinical application: using innovation in pharmacogenomics and clinical decision support, it offered the most comprehensive medication risk management program on the market, combining DNA testing interpretation, interactive education, and access to clinical experts to guide patients and providers to personalized health choices. On March 19, 2025, InformedDNA announced the acquisition of Coriell Life Sciences, combining its pharmacogenomics expertise with InformedDNA's genetic test interpretation and counseling services; Megill became InformedDNA's Chief Commercial Officer and the new DNAimpact platform expanded access to a broader range of genetic insights.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Founded
Scott Megill co-founded Coriell Life Sciences as a spin out from the Coriell Institute for Medical Research, building a precision-medicine business around pharmacogenomics and medication risk management.
- Acquired by InformedDNA
On March 19, 2025, InformedDNA announced the acquisition of Coriell Life Sciences, expanding its precision health capabilities; CEO Scott Megill took on the role of Chief Commercial Officer of InformedDNA.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Raised approximately $9.47 million in total.
- 02
In March 2025 it was acquired by InformedDNA on undisclosed terms; CEO Scott Megill became InformedDNA's chief commercial officer.
- 03
No audited loss figure was publicly disclosed.